InterCure Ltd.

NasdaqGM:INCR Stock Report

Market Cap: US$64.2m

InterCure Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for InterCure.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth23.9%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

InterCure: A Cannabis Industry Leader Still Flying Under The Radar

Jun 30

InterCure: Bargain Israel Cannabis Play

Apr 22

InterCure: A Leader In Global Cannabis

Sep 06

InterCure reports Q2 results

Aug 15

InterCure Is Growing In The Massive Global Cannabis Market

Jun 07

IntureCure: Israel Recreation Cannabis Boom On The Way

Feb 16

InterCure Chairman Ehud Barak, CEO Alex Rabinovitch - Israel Cannabis And Beyond (Video)

Nov 08

InterCure: Internationally Profitable Cannabis (Podcast Transcript)

Sep 19

InterCure: Ignored Uplisting

Sep 09

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as InterCure has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NasdaqGM:INCR - Analysts future estimates and past financials data (ILS Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/2024273-66N/AN/AN/A
3/31/2024312-61N/AN/AN/A
12/31/2023356-62-56-54N/A
9/30/2023388-20N/AN/AN/A
6/30/202341521N/AN/AN/A
3/31/202340832-18-4N/A
12/31/2022389453251N/A
9/30/202236333-617N/A
6/30/202232424424N/A
3/31/202227415725N/A
12/31/202122051630N/A
9/30/2021167172032N/A
6/30/2021128201225N/A
3/31/20219413219N/A
12/31/202065-37-138N/A
9/30/202040-63-25-3N/A
6/30/202020-80-42-16N/A
3/31/202011-91-47-13N/A
12/31/20199-6-40-12N/A
9/30/201977-33-11N/A
6/30/2019518-18-5N/A
3/31/2019227-4-3N/A
12/31/2018N/A-13-2-1N/A
9/30/2018N/A-10-1-1N/A
6/30/2018N/A-8-1-1N/A
3/31/2018N/A-7N/A-1N/A
12/31/2017N/A-6N/A-1N/A
9/30/2017N/A-4N/A-1N/A
6/30/2017N/A-2N/A-1N/A
3/31/2017N/A-2N/A-1N/A
12/31/2016N/A0N/A-1N/A
9/30/201600N/A-1N/A
6/30/20160-1N/A-1N/A
3/31/201610N/A-1N/A
12/31/20151-2N/A-2N/A
9/30/20152-1N/A-1N/A
6/30/20153-2N/A-1N/A
3/31/20154-4N/A-1N/A
12/31/20146-4N/A-2N/A
9/30/20147-5N/A-2N/A
6/30/20147-5N/A-2N/A
3/31/20148-6N/A-3N/A
12/31/20138-7N/A-3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if INCR's forecast earnings growth is above the savings rate (2.6%).

Earnings vs Market: Insufficient data to determine if INCR's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if INCR's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if INCR's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if INCR's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if INCR's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y